Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin HIV AIDS. 2012 Mar;7(2):164-71. doi: 10.1097/COH.0b013e3283504a66.

Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup.

Author information

1
Seattle Biomedical Research Institute, Seattle, Washington, USA.

Abstract

PURPOSE OF REVIEW:

This review summarizes the role of CD3+CD4-CD8- double-negative T cells, which have both regulatory and helper T-cell functions and may have the potential to compensate for the reduced levels of CD4 T cells during SIV/HIV infection.

RECENT FINDINGS:

Double-negative T cells have been characterized in several human diseases and in murine models of autoimmunity and transplantation, where they exhibit both immunoregulatory and helper T-cell-like function. During the natural nonpathogenic SIV infection of African nonhuman primates, the lack of clinical disease progression is associated with the presence of double-negative T cells that maintain helper T-cell functions while remaining refractory to viral infection. Moreover, DN T cells may compensate for very low levels of CD4+ T cells observed in a cohort of SIV-infected sooty mangabeys that have remained free of clinical AIDS for over 10 years. These studies identify a potential for double-negative T cells to provide critical helper function during HIV infection.

SUMMARY:

Double-negative T cells with some CD4+ T-cell functions are associated with a nonpathogenic outcome during SIV infection and represent a potential immune therapeutic target in HIV-infected patients.

PMID:
22241163
PMCID:
PMC3639317
DOI:
10.1097/COH.0b013e3283504a66
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Support Center